As per a new study, the potential of mRNA vaccines offers a personalized treatment for patients with pancreatic cancer.
Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho on Monday but did not take a vote.
Moderna (MRNA) has disclosed a new risk, in the Sales & Marketing category. Moderna faces significant commercial challenges, particularly in ...